% | $
Quotes you view appear here for quick access.

Tekmira Pharmaceuticals Corporation Message Board

investron 168 posts  |  Last Activity: Nov 27, 2015 8:28 PM Member since: Feb 15, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • by investron Nov 27, 2015 8:28 PM Flag

    Expect secondary in 90 days for following reasons:
    by tene1961 • 34 minutes ago

    Expect secondary in 90 days for following reasons:
    1. ARWR had last public offering in Feb. 2014
    2. ARWR raised about 100 million cash at 18.95 per share in Feb. 2014
    3. Cash was down to about 85 million at time of secondary in 2014
    4. Cash will be down to 85-88 mil. in 4 weeks at end of 4Q 2015
    5. Cash burn rate will only increase with more clinical candidates, trials and preclinical development in 2016
    6. ARWR needs more money and time to establish whether top candidate ARC 520/combo will lead to FC's
    7. ARWR is not going to let cash get down too low with high quarterly cash burn and then need massive secondary to replenish


    Told ya about jagan1961, tene1961, henryzsu, ccribber2, end2war too.

    Once these guys sold or bought they would start to work the board hard.

    Here are some of the holes in the above:

    ARWR's cash was INCREASING after a $60 million offering.

    The reason for the bigger offering soon after was then because the stock was in demand.

    The share price was 3-4X higher than the previous offer.

    After, I projected that ARWR would have another offering in the $30s.

    ARWR doesn't "need" but it certainly can use.

    Last call to leave with Holden Caulfield, end2war, and all the other hairdressers on the B-Ark for the new MB.

    If you stay get this through your head, for what it can do, ARWR doesn't need $100 million, it should strategize for $1,000 million.

  • Reply to

    $150 On HBV Success

    by investron Nov 27, 2015 9:33 AM investron Nov 27, 2015 1:21 PM Flag

    What's wrong with you lemmings, desperate to hear from this and that master?

    Shouldn't you be on the new and improved ARWR message board by now?

    $150 on HBV success only puts ARWR's market cap at $9 billion or so.

    Just ARC-AAT's success can take ARWR's market cap to $4 billion as an orphan drug house.

    Pharmasset sold for more than $11 billion and that's it, just one application, HCV.

    Goldman Sachs lowballed it to look good and conservative.

    The truth of the matter is, for ARWR, HBV would be just a starter.

    You ain't seen nuthin yet.

  • by investron Nov 27, 2015 12:46 PM Flag

    said Goldman Sachs.

    We did better!

    Sentiment: Strong Buy

  • Reply to

    $150 On HBV Success

    by investron Nov 27, 2015 9:33 AM investron Nov 27, 2015 12:42 PM Flag

    ccribber2 • 1 hour 2 minutes ago

    C'mon investron, why the bogus message? What, do you need to dig up cash for property taxes or something? You look pretty bad right now.

    ccribber2 • 51 minutes ago

    What!!!! 3 thumbs down? investron get thumbs up for posing false info, some of you are pretty sad investors. Dont cheat people folks, let the facts speak for themselves and those who post lies should be exposed.


    DRATER (That's ccribber2 spelled backward.)

    At least you got one thumb up your hole from a fellow drater.


  • Reply to

    $150 On HBV Success

    by investron Nov 27, 2015 9:33 AM investron Nov 27, 2015 12:34 PM Flag

    Think I'm lying?

    Let's hear it from your master, lemmings:

    hparch • Feb 18, 2015 2:26 PM

    Goldman Sachs said:

    1 log KD = $50/share
    FC = $150/share

    Sentiment: Strong Buy

  • by investron Nov 27, 2015 10:14 AM Flag

    what don't you like about all the developments?

    When this catches fire, and it's starting to smoke, being close to the exit will save your lives.

    Waste no time and start inching for it.

    This thing is about to explode.

  • Starting from here I think we'll do it in less than one.

    Gentlemen, place your bets.

    Sentiment: Strong Buy

  • This company is on the verge of major recognition.

    ALNY, here we come.

  • Three years later the proofs are coming in.

    Every single trial has been a success.

    Houston, we have a lift off.

  • by investron Nov 27, 2015 9:33 AM Flag

    according to Goldman Sachs.

    I think we did it.

  • by investron Nov 25, 2015 11:04 AM Flag

    to all the hairdressers leaving on the B-Ark to colonize a newer and better ARWR message board.

    Good luck!

    Have fun moderating, censoring, deleting each other's posts.

    I am sure nobody will miss them.

  • by investron Nov 25, 2015 10:54 AM Flag

    to ARWR surpassing ISIS and ALNY.

    My long standing predictions.

    The science is looking the part, it's time for the share price to catch up.

  • by investron Nov 25, 2015 4:54 AM Flag

    why Novartis bequeathed its billion dollar RNAi assets to ARWR and became a major share holder earlier this year?

    This stock should have gone through the roof then but for the usual suspects who came out to actively take down ARWR with price target downgrade.

    Understand that the stake is huge and some parties are going to make $billions upon $billions.

    ARWR is a thousand times KBIO for a starter, its universe is infinitely larger.

    Hang on for dear life and wirite your own ticket.

  • investron Nov 24, 2015 7:19 PM Flag

    I would love it if they did a $100Mn secondary at $5. That would give them almost 3 years of cash." - holden caulfield, Nov. 23, 2015.

    The left over from nonotech days crowd just doesn't get it what ARWR's science obtained from Roche and now fortified with Novartis' RNAi assets can do.

    ARWR doesn't need $100 million.

    3 years of cash? That's totally #$%$.

    ARWR can use n $1,000 million to pump out candidates the technology can vett in days.

    If you think ISIS can pump out garbage hoping a few will stick, ARWR can pump it out and only the good stuff.

    If that idiot Dirk Haussecker had a real brain and didn't have to quit research, he would have figured it out that it's ARWR that will be the more valuable.

    In stead Mr. second rate got it all wrong on just about everything including ARWR vs. TKMR/ABUS.

    See for yourself, where is the much pumped TKMR/ABUS in his portfolio now?

    Replaced by the much maligned ARWR!

  • "I heard he [Martin Shrekli] is taking out ARWR for $750Bn Happy days are here again. La La La La" - holden caulfield, Nov. 24, 2015.

    "I was fortunate enough to have a great year last month. I had been buying this below $5 to double my position. Kind of disappointed that the stock has rebounded somewhat. I would love it if they did a $100Mn secondary at $5. That would give them almost 3 years of cash. It would leave them with 82Mn shares." - holden caulfield, Nov. 23, 2015.

    "I spoke with four institutional investors about this. One of them has been successfully trading it. Has no position right now. In general, though, they don't care about monkeys. They don't care about KD. They care if humans (plural) are cured. They think its coming but maybe not for 6-8 months." - holden caulfield, Nov. 16, 2015.

    Make them pay triple digits.

    "Can't wait 6-8 months" idiots.

    It makes you wonder where these morons hope to invest and lift themselves out of anonymity after 30 years of mediocre performance?

    The utter failure of public education type thinks science like ARWR's comes around all the time, $5 is just too much for their rent money between now and then.

    Leave them staring on the sidelines counting their pennies like end2war and one time 40,000 shares of AAPL

    Stupid is as stupid does (and posts).

    Sentiment: Strong Buy

  • by investron Nov 24, 2015 2:56 PM Flag

    Opdivo, Bristol Meyers Squib(sp?), was recently approved by the FDA for the treatment of metastatic RCC. Take a look at the awful side effects opdivo has and how NOT very effective it is. Yet, it was approved by the FDA. You can look at the FDA release and then the opdivo website (for side effects). - postcalloff

    And this thing trades in the $300 million, a fifth of what Roche and Novartis put into the IPs alone???

    It's time to squeeze the shorts and massively fund this company and revolutionize medicine.

    This is potentially the most valuable company EVER.

    Today the science has virtually been made real by the incredible breadth of actual results.

    It makes your head spin even more just trying to wrap your mind around such potential.

    Yet the price has been pushed down as if everything failed rather than the absolutely stellar results.

    ARWR is infinitely any number of KBIO combined, literally.

    We can put so many candidates into the pipeline all it takes is dollars.

    The life that will be saved may very well be you or yours.

    Waste no more time!

    investron • Feb 26, 2013 9:54 AM

    Somebody asked me what would be the upper limits of this stock?

    I told him truthfully I didn't know.

    It boggles my mind.

    The implications of the science are vast.

    Sentiment: Strong Buy

  • by investron Nov 24, 2015 1:47 PM Flag

    ARWR shorts are about making money without regard to destroying life-saving science.

    Martin Shrekli should make a lot of money from ARWR shorts.

  • by investron Nov 24, 2015 11:01 AM Flag

    First big short to cover will trap the rest.

    The exit is very small.

    Remaining holders are in for the big buck$.

  • Reply to

    Pull The Borrow - Shorts Executed

    by investron Nov 23, 2015 8:21 PM investron Nov 24, 2015 9:43 AM Flag

    I'd hate to be short on KBIO. Imagine having to liquidate your retirement and whatever assets you own... - tltrooper

    If KBIO's $45 hurts, imagine ARWR's $145.

    Remember, Goldman Sachs suggested $150 on likelihood of HBV success.

    But HBV is truly just the beginning of this stock.

    KBIO is simply no comparison.

  • Thanks to all the news, this is HOT topic.

    ARWR has a massive short hang over in excess of 25%!

    Yet the future is blindingly bright, and that may be an understatement.

    The news have been just absolutely incredibly good and making the flat pps rather insane.

    This artificial lid is just waiting to blow.

5.51+0.04(+0.73%)Nov 27 1:00 PMEST